Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20‐17/KM23 trial
Saved in:
| Main Authors: | Kyoungmin Lee, Kyung‐Hun Lee, Dong‐Wan Kim, Jeesun Yoon, Yoon Ji Choi, Soohyeon Lee, Ju Won Kim, Kyong Hwa Park, Wonyoung Choi, Youngjoo Lee, Hyewon Ryu, Dong‐Hoe Koo, YunGyoo Lee, Hei‐Cheul Jeung, Min‐Young Lee, Namsu Lee, Myoung Joo Kang, Jieun Lee, Sook Hee Hong, Eun Joo Kang, In Hae Park |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Cancer Communications |
| Online Access: | https://doi.org/10.1002/cac2.70026 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of germline BRCA1/2 pathogenic variants in unselected Korean patients with HER2-negative metastatic breast cancer: a nationwide prospective study (KCSG BR19-10)Research in context
by: Hee Kyung Ahn, et al.
Published: (2025-07-01) -
A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)
by: Dong Ki Lee, et al.
Published: (2024-12-01) -
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15)
by: Jieun Lee, et al.
Published: (2025-08-01) -
Differential Effect of Sex on Mortality According to Age in Heart Failure
by: Yoonpyo Lee, et al.
Published: (2024-08-01) -
Author Correction: Risk factors for and incidence of osteoporosis in patients with breast cancer by gender : a nationwide cohort study
by: Jin Ah Lee, et al.
Published: (2025-05-01)